TribLIVE

| Business


 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

J&J wins U.S. approval for TB tablet

Email Newsletters

Click here to sign up for one of our email newsletters.

On the Grid

From the shale fields to the cooling towers, Trib Total Media covers the energy industry in Western Pennsylvania and beyond. For the latest news and views on gas, coal, electricity and more, check out On the Grid today.

JNJ $70.10 +$0.62

at close on MONDAY

Daily Photo Galleries

By Anna Edney C.2012 Bloomberg News
Monday, Dec. 31, 2012, 10:30 p.m.
 

Johnson & Johnson won regulatory approval for its tuberculosis tablet Sirturo, the first drug in 40 years that provides a new way to treat the contagious lung infection.

The Food and Drug Administration cleared Sirturo to be added to therapies for use by adults whose illness is resistant to multiple medicines, the New Brunswick, N.J.- based company said Monday.

While tuberculosis was once the leading cause of death in the nation, the drug-resistant version of the illness affected about 98 people last year, according to the Centers for Disease Control and Prevention.

Subscribe today! Click here for our subscription offers.

 

 


Show commenting policy

Most-Read Business Headlines

  1. Pope’s South American homecoming to spotlight poor, environment
  2. How to land that 1st job after college
  3. New J.C. Penney CEO comes from middle-income America
  4. Corporate America speaking out on social issues, getting results
  5. After years of downsizing, big houses make comeback
  6. Truffle dogs sniff out pungent fungus prized by foodies
  7. Importance stressed of securing your online banking
  8. Floating homes offer ‘affordable’ option in San Francisco area
  9. McDonald’s localizes menus to battle growing competition
  10. Aetna to buy rival Humana for $35B
  11. Airlines offer small conveniences to counter higher fees, less space